WORLD CANCER DAY 2026,4TH FEBRUARY:PREVENTION, PRECISION ONCOLOGY AND ONE HEALTH INTEGRATION
Theme: Closing the Care Gap
Introduction: Cancer Beyond a Medical Diagnosis
Cancer transcends a mere disease; it poses a biological, environmental, social, and economic challenge. World Cancer Day, observed annually on 4 February, underscores the urgent need to reduce disparities in cancer prevention, early detection, diagnosis, treatment, and survivorship care. The 2026 theme, “Closing the Care Gap,” stresses that scientific advances must reach all communities, regardless of geography, income, gender, or age. This demands integrating clinical medicine, public health policy, environmental stewardship, veterinary science, adolescent education, and community awareness via the One Health framework, which recognizes the interdependence of human, animal, and environmental health.
Biological Basis of Cancer
Cancer arises when normal cellular regulatory mechanisms fail. Deoxyribonucleic Acid (DNA), the hereditary material directing cell growth, division, and apoptosis (programmed cell death), holds the blueprint. Mutations,from inherited factors, lifestyle exposures, infections, or environmental toxins—activate oncogenes (driving uncontrolled growth) or inactivate tumor suppressor genes like p53 (which curb abnormal proliferation).
Key processes in cancer progression include:
Angiogenesis: new blood vessel formation to nourish tumors.
Metastasis: cancer cell spread to distant organs via blood or lymphatics.
Oxidative stress: reactive oxygen species damaging DNA and cellular structures.
Epigenetic changes: reversible modifications altering gene expression without DNA sequence alterations.
These insights enable targeted prevention, detection, and treatment.
Environmental Degradation, One Health, and Cancer Risk
The One Health framework highlights interconnections among human, animal, and environmental health. Environmental degradation—polluted air, contaminated water, chemical-laden soil—elevates cancer risk directly and indirectly. Airborne pollutants like fine particulate matter (PM2.5), polycyclic aromatic hydrocarbons (PAHs), and heavy metals spark chronic inflammation and DNA damage. Waterborne arsenic, pesticides, and industrial effluents induce mutations in gastrointestinal, liver, and kidney cells. Soil/food contamination bioaccumulates via crops and livestock, amplifying human exposure.
Animals act as sentinels, signaling environmental toxicity early. Pollutants disrupt hormones, trigger epigenetics, and accelerate carcinogenesis. One Health integration is vital for prevention, sustainable policy, and closing care gaps.
Pediatric and Adolescent Oncology
Childhood and adolescent cancers differ biologically from adult ones, often stemming from spontaneous genetic mutations rather than cumulative exposures. Common types: acute lymphoblastic leukemia (ALL), brain tumors, lymphomas, osteosarcoma.
Adolescence demands preventive education:
HPV vaccination (ages 9–14) prevents cervical cancer.
Guidance on menstrual hygiene, nutrition, physical activity, and avoiding tobacco/alcohol cuts long-term risk.
Boys: promote activity and mental engagement; girls: emphasize reproductive health.
Early detection, vaccination, and education boost outcomes.
Women’s Health, Menstrual Hygiene, and Policy Measures
Women bear high risks from breast and cervical cancers, the latter mainly from persistent Human Papillomavirus (HPV) infection. Papanicolaou (Pap) smears and HPV DNA testing enable early intervention.
India’s Supreme Court mandates free/affordable sanitary napkins for schoolgirls. Poor menstrual hygiene fosters reproductive tract infections and inflammation, potentially raising DNA damage and cancer susceptibility.
Lifestyle risks obesity, delayed childbirth, limited breastfeeding, alcohol, inactivity elevate breast cancer odds. Education, screening, and hygiene access form integrated prevention.
Molecular Oncology and Precision Medicine
Tumor molecular profiling guides therapy:
HER2 (Human Epidermal Growth Factor Receptor 2) overexpression fuels aggressive breast cancer.
EGFR (Epidermal Growth Factor Receptor) mutations link to lung/colorectal cancers.
Precision oncology customizes treatment: targeted therapies halt aberrant pathways; immunotherapies like Chimeric Antigen Receptor T-cell (CAR-T) therapy rally immune attacks.
Accessible diagnostics:
Magnetic Resonance Imaging (MRI): magnetic fields/radio waves for organ visualization.
Computed Tomography (CT): cross-sectional X-rays.
Positron Emission Tomography (PET): metabolic activity detection.
Liquid biopsy: circulating tumor DNA in blood for early monitoring.
Emerging Biomarkers: Earwax (Cerumen)
Research reveals cerumen (earwax) mirrors cancer-induced systemic changes. Gas Chromatography–Mass Spectrometry (GC-MS) identifies cancer-specific volatile organic compounds/metabolites. This non-invasive, low-cost method suits low-resource settings, though experimental.
Artificial Intelligence in Oncology
Artificial Intelligence (AI) sharpens detection and planning. Radiomics pulls quantitative features from images, spotting subtle tumors. Paired with molecular/liquid biopsy data, AI personalizes therapy and bridges resource gaps.
Economic Accessibility and Government Initiatives
Cancer care strains finances. India’s recent Union Budgets cut duties/taxes on drugs like targeted therapies/chemotherapies, enhancing affordability.
Diagnostics (MRI/CT/PET, molecular tests) must follow suit for early detection and survival gains.
Veterinary Contributions and Translational Research
Veterinarians advanced COVID-19 vaccines via animal models, exemplifying translational research. Such collaboration bolsters cancer studies, environmental surveillance, and immunotherapy.
Policy, Awareness, and Closing the Care Gap
Key actions:
Affordable medicines/diagnostics.
Expanded screening/rural outreach.
Environmental/toxicology monitoring.
Adolescent/gender-sensitive education.
WHO/IARC collaboration.
Awareness of lifestyle, hygiene, vaccination, and environmental duty complements medicine.
Conclusion
Cancer, biologically intricate, yields to:
Prevention/early detection.
Precision therapy/molecular profiling.
AI/liquid biopsy.
One Health environmental regulation.
Adolescent/women’s programs.
Affordable access.
“Closing the Care Gap” obliges equitable science delivery. Unified medicine, policy, education, and stewardship close it.
Author:
Dr. Simant Kumar Nanda
MVSc (Pharmacology)
Former Joint Director, Animal Resources Development Department, Government of India
Bhubaneswar
Mob: +91-9937500810
